FDA Drug Application (050429) for RIMACTANE by OXFORD PHARMS

Back to FDA Applications sponsored by OXFORD PHARMS

Application Number050429
Product Number001
FormCAPSULE;ORAL
Dosage300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRIMACTANE
Active IngredientRIFAMPIN

Active IngredientCount
List of drugs with Active Ingredient RIFAMPIN6


Back to FDA Applications sponsored by OXFORD PHARMS